IP Library Granted Patent US 11,833,291
Granted Patent B2
US 11,833,291 · App. 17/874,531 · Granted Dec 5, 2023

Preservative-free single dose inhaler systems

Inventors: John S. Patton (San Francisco, CA); Ryan S. Patton (San Francisco, CA); Mei-chang Kuo (Palo Alto, CA); Yehuda Ivri (Newport Beach, CA)
Assignee: Aerami Therapeutics, Inc.
A61M15/0028A61K9/0073A61K9/122A61K33/30A61K38/28A61M11/00A61M11/001A61M11/005A61M15/009A61M15/0021A61M15/0065A61M15/0085A61M15/0091A61M2016/0021A61M2016/0039A61M2202/0468A61M2205/3334A61M2205/583A61M2205/587
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,833,291
App. No.
17/874,531
Granted
Dec 5, 2023
Kind
B2
Abstract

An aerosolization system includes a container that is configured to deliver a unit dosage of a liquid when squeezed a single time. The system also includes an aerosolizer that is constructed of a housing defining a mouthpiece, and an aerosol generator disposed in the housing. The aerosol generator includes a vibratable membrane having a front face and a rear face, and a vibratable element used to vibrate the membrane. Further, the housing includes an opening that is adapted to receive a unit dosage of the liquid from the container. The opening provides a liquid path to the rear face of the vibratable membrane.

Claims (50)

1. A method of aerosolizing a volume of liquid medicament, comprising:

providing an inhaler, comprising:

a housing comprising a mouthpiece and a liquid receptacle fluidly coupled to the mouthpiece, wherein the liquid receptacle defines an opening that extends through an exterior surface of the housing at an inlet end of the opening;

an aerosol generator disposed within the housing, the aerosol generator comprising:

a membrane having a front face, a rear face, and a plurality of apertures that extend between the front face and the rear face; and

a vibratable element; and

a visual indicator, wherein an inlet end of the opening is positioned between, and in general alignment with, the mouthpiece and the visual indicator, with the visual indicator and the opening being positioned on a same surface of the housing and the visual indicator being oriented such that the visual indicator is visible to a user of the inhaler while the user inhales through the mouthpiece;

detecting fluid flow through the mouthpiece as the user inhales using a flow sensor;

activating the vibratable element in response to detecting the fluid flow to aerosolize a dosage of the liquid medicament that has been supplied to the rear face of the membrane as the user inhales via the mouthpiece; and

providing, using the visual indicator, an indication that the entire dosage of liquid has been aerosolized.

2. The method of aerosolizing a volume of liquid medicament of claim 1 , further comprising:

providing, using the visual indicator, an indication that the dosage of liquid medicament has been received within a receiving chamber within the housing.

3. The method of aerosolizing a volume of liquid medicament of claim 2 , wherein:

the visual indicator comprises a first light that provides the indication that the dosage of liquid medicament has been received within the receiving chamber and a second light that provides the indication that the entire dosage of liquid has been aerosolized.

4. The method of aerosolizing a volume of liquid medicament of claim 3 , wherein:

providing the indication that the dosage of liquid medicament has been received within the receiving chamber comprises blinking the first light.

5. The method of aerosolizing a volume of liquid medicament of claim 1 , wherein:

the housing comprises a funnel coupled with the opening, the funnel directing the liquid medicament to the rear face of the membrane.

6. The method of aerosolizing a volume of liquid medicament of claim 5 , wherein:

a slope of the funnel is at least 30 degrees relative to a central axis of the opening.

7. A method of aerosolizing a volume of liquid medicament, comprising:

providing an indication that a dosage of the liquid medicament has been received by an inhaler via an opening formed through a housing of the inhaler;

detecting fluid flow through a mouthpiece of the inhaler as a user inhales through the mouthpiece using a flow sensor of the inhaler;

activating an aerosol generator of the inhaler in response to detecting the fluid flow to aerosolize the dosage of liquid medicament that has been supplied to a rear face of a membrane of the aerosol generator as the user inhales via the mouthpiece; and

providing an indication that the entire dosage of liquid has been aerosolized using a visual indictor of the inhaler, wherein an inlet end of the opening is positioned between, and in general alignment with, the mouthpiece and the visual indicator, with the visual indicator and the opening being positioned on a same surface of the housing and the visual indicator being oriented such that the visual indicator is visible to the user while the user inhales through the mouthpiece.

8. The method of aerosolizing a volume of liquid medicament of claim 7 , wherein:

the visual indicator is positioned in alignment with a center of the mouthpiece along a central axis of the inhaler.

9. The method of aerosolizing a volume of liquid medicament of claim 7 , wherein:

the inhaler comprises a funnel that directs the dosage of liquid medicament to the rear face of the membrane.

10. The method of aerosolizing a volume of liquid medicament of claim 9 , wherein:

the funnel comprises a maximum diameter of between about 10 mm and 15 mm and an opening to the funnel is at least 5 mm.

11. The method of aerosolizing a volume of liquid medicament of claim 7 , wherein:

the aerosol generator comprises a vibratable element that vibrates the membrane.

12. The method of aerosolizing a volume of liquid medicament of claim 11 , wherein:

the vibratable element vibrates at a rate of between about 50 kHz to 150 kHz.

13. The method of aerosolizing a volume of liquid medicament of claim 7 , wherein:

delivery of the entire dosage comprises delivery of 98% or more of the liquid medicament received by the inhaler.

14. A method of aerosolizing a volume of liquid medicament, comprising:

detecting fluid flow through a mouthpiece of an inhaler as a user inhales through the mouthpiece using a flow sensor of the inhaler;

activating an aerosol generator of the inhaler in response to detecting the fluid flow to aerosolize a dosage of the liquid medicament that has been supplied to the aerosol generator via an opening formed through a housing of the inhaler as the user inhales via the mouthpiece; and

providing an indication that the entire dosage of liquid has been aerosolized using a visual indictor of the inhaler, wherein an inlet end of the opening is positioned between, and in general alignment with, the mouthpiece and the visual indicator, with the visual indicator and the opening being positioned on a same surface of the housing and the visual indicator being oriented such that the visual indicator is visible to the user while the user inhales through the mouthpiece.

15. The method of aerosolizing a volume of liquid medicament of claim 14 , wherein:

activating the aerosol generator comprises vibrating a vibratable member that is coupled with a dome-shaped membrane.

16. The method of aerosolizing a volume of liquid medicament of claim 14 , wherein:

the visual indicator comprises at least one light.

17. The method of aerosolizing a volume of liquid medicament of claim 14 , wherein:

an exterior housing of the inhaler defines the opening through which the liquid medicament is delivered to the aerosol generator; and

the opening and the visual indicator are disposed on a same wall of the exterior housing.

18. The method of aerosolizing a volume of liquid medicament of claim 14 , further comprising:

providing an indication that the dosage of liquid medicament has been received by the inhaler.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 10, 2023
From: PATTON, JOHN S.; PATTON, RYAN S.; KUO, MEI-CHANG; IVRI, YEHUDA
To: DANCE PHARMACEUTICALS INC
Reel/Frame 063593/0492 →
CHANGE OF NAME Recorded May 10, 2023
From: DANCE BIOPHARM INC.
To: AERAMI THERAPEUTICS, INC.
Reel/Frame 063594/0928 →
CHANGE OF NAME Recorded May 10, 2023
From: DANCE PHARMACEUTICALS, INC.
To: DANCE BIOPHARM INC.
Reel/Frame 064298/0464 →
Continuity (7)
Continuation 16685382 · Nov 15, 2019
Continuation 15165662 · May 26, 2016
Continuation 14606623 · Jan 27, 2015
Continuation 14039254 · Sep 27, 2013
Continuation 13004662 · Jan 11, 2011
Provisional Application 61335769 · Jan 12, 2010
Related Publication 20230051645A1 · Feb 16, 2023